img

Global Gammaretroviral Vector Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gammaretroviral Vector Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Gammaretroviruses are retroviral vectors in laboratory studies. These vectors are critical for gene therapy and gene transfer. They are so helpful because their genomes are simple and easy to use. Gammaretroviruses have a wide range of implications for animals. They have been linked to various diseases, including cancer, specifically leukemias and lymphomas, neurological diseases, and immunodeficiencies in multiple species. Gammaretroviruses, like other retroviruses, reverse transcribe a positive single strand RNA into double stranded DNA. The double-stranded DNA is highly stable and easily integrated into the host genome. Moloney murine leukaemia virus, xenotropic MuLB-related virus, feline leukaemia virus, and feline sarcoma virus are some examples of the virus.
Gammaretroviral Vector report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gammaretroviral Vector market is projected to reach US$ 13270 million in 2029, increasing from US$ 4991 million in 2022, with the CAGR of 15.0% during the period of 2024 to 2029. Demand from Gene Therapy and Vaccinology are the major drivers for the industry.
According to the World Health Organization, lung cancer is the leading cause of cancer death, followed by breast cancer and colorectal cancer. Breast cancer, lung cancer, prostate cancer, colon cancer, and rectum cancer are the most frequent cancers. The rising frequency of cancer, genetic illnesses, and infectious diseases is boosting demand for vector-based gene treatments, cell therapies, and vaccines, which is one of the primary drivers of the global gammaretroviral vector market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gammaretroviral Vector market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novasep
MerckKGaA
Charles River Laboratories
UniQure N.V.
Waisman Biomanufacturing
Creative-Biogene
Aldevron
Addgene
Oxford Biomedica
Thermo Fisher Scientific Inc.
Fujifilm Corporation
Spark Therapeutics Inc
ABL Inc
Boehringer Ingelheim International GmbH
Brammer Bio
Creative Biogene
General Electric
Pfizer Inc
Genezen
Segment by Type
Lentiviral Vectors
Adenoviral Vectors
Adeno-Associated Viral Vectors
Other

Segment by Application


Gene Therapy
Vaccinology
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gammaretroviral Vector market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gammaretroviral Vector, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gammaretroviral Vector industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Gammaretroviral Vector in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gammaretroviral Vector introduction, etc. Gammaretroviral Vector Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Gammaretroviral Vector market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Gammaretroviral Vector Market Overview
1.1 Gammaretroviral Vector Product Overview
1.2 Gammaretroviral Vector Market Segment by Type
1.2.1 Lentiviral Vectors
1.2.2 Adenoviral Vectors
1.2.3 Adeno-Associated Viral Vectors
1.2.4 Other
1.3 Global Gammaretroviral Vector Market Size by Type
1.3.1 Global Gammaretroviral Vector Market Size Overview by Type (2018-2029)
1.3.2 Global Gammaretroviral Vector Historic Market Size Review by Type (2018-2024)
1.3.3 Global Gammaretroviral Vector Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gammaretroviral Vector Sales Breakdown by Type (2018-2024)
1.4.2 Europe Gammaretroviral Vector Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Gammaretroviral Vector Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Gammaretroviral Vector Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Gammaretroviral Vector Sales Breakdown by Type (2018-2024)
2 Global Gammaretroviral Vector Market Competition by Company
2.1 Global Top Players by Gammaretroviral Vector Sales (2018-2024)
2.2 Global Top Players by Gammaretroviral Vector Revenue (2018-2024)
2.3 Global Top Players by Gammaretroviral Vector Price (2018-2024)
2.4 Global Top Manufacturers Gammaretroviral Vector Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gammaretroviral Vector Market Competitive Situation and Trends
2.5.1 Gammaretroviral Vector Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Gammaretroviral Vector Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gammaretroviral Vector as of 2022)
2.7 Date of Key Manufacturers Enter into Gammaretroviral Vector Market
2.8 Key Manufacturers Gammaretroviral Vector Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gammaretroviral Vector Status and Outlook by Region
3.1 Global Gammaretroviral Vector Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Gammaretroviral Vector Historic Market Size by Region
3.2.1 Global Gammaretroviral Vector Sales in Volume by Region (2018-2024)
3.2.2 Global Gammaretroviral Vector Sales in Value by Region (2018-2024)
3.2.3 Global Gammaretroviral Vector Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Gammaretroviral Vector Forecasted Market Size by Region
3.3.1 Global Gammaretroviral Vector Sales in Volume by Region (2024-2029)
3.3.2 Global Gammaretroviral Vector Sales in Value by Region (2024-2029)
3.3.3 Global Gammaretroviral Vector Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Gammaretroviral Vector by Application
4.1 Gammaretroviral Vector Market Segment by Application
4.1.1 Gene Therapy
4.1.2 Vaccinology
4.1.3 Other
4.2 Global Gammaretroviral Vector Market Size by Application
4.2.1 Global Gammaretroviral Vector Market Size Overview by Application (2018-2029)
4.2.2 Global Gammaretroviral Vector Historic Market Size Review by Application (2018-2024)
4.2.3 Global Gammaretroviral Vector Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gammaretroviral Vector Sales Breakdown by Application (2018-2024)
4.3.2 Europe Gammaretroviral Vector Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Gammaretroviral Vector Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Gammaretroviral Vector Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Gammaretroviral Vector Sales Breakdown by Application (2018-2024)
5 North America Gammaretroviral Vector by Country
5.1 North America Gammaretroviral Vector Historic Market Size by Country
5.1.1 North America Gammaretroviral Vector Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Gammaretroviral Vector Sales in Volume by Country (2018-2024)
5.1.3 North America Gammaretroviral Vector Sales in Value by Country (2018-2024)
5.2 North America Gammaretroviral Vector Forecasted Market Size by Country
5.2.1 North America Gammaretroviral Vector Sales in Volume by Country (2024-2029)
5.2.2 North America Gammaretroviral Vector Sales in Value by Country (2024-2029)
6 Europe Gammaretroviral Vector by Country
6.1 Europe Gammaretroviral Vector Historic Market Size by Country
6.1.1 Europe Gammaretroviral Vector Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Gammaretroviral Vector Sales in Volume by Country (2018-2024)
6.1.3 Europe Gammaretroviral Vector Sales in Value by Country (2018-2024)
6.2 Europe Gammaretroviral Vector Forecasted Market Size by Country
6.2.1 Europe Gammaretroviral Vector Sales in Volume by Country (2024-2029)
6.2.2 Europe Gammaretroviral Vector Sales in Value by Country (2024-2029)
7 Asia-Pacific Gammaretroviral Vector by Region
7.1 Asia-Pacific Gammaretroviral Vector Historic Market Size by Region
7.1.1 Asia-Pacific Gammaretroviral Vector Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Gammaretroviral Vector Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Gammaretroviral Vector Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Gammaretroviral Vector Forecasted Market Size by Region
7.2.1 Asia-Pacific Gammaretroviral Vector Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Gammaretroviral Vector Sales in Value by Region (2024-2029)
8 Latin America Gammaretroviral Vector by Country
8.1 Latin America Gammaretroviral Vector Historic Market Size by Country
8.1.1 Latin America Gammaretroviral Vector Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Gammaretroviral Vector Sales in Volume by Country (2018-2024)
8.1.3 Latin America Gammaretroviral Vector Sales in Value by Country (2018-2024)
8.2 Latin America Gammaretroviral Vector Forecasted Market Size by Country
8.2.1 Latin America Gammaretroviral Vector Sales in Volume by Country (2024-2029)
8.2.2 Latin America Gammaretroviral Vector Sales in Value by Country (2024-2029)
9 Middle East and Africa Gammaretroviral Vector by Country
9.1 Middle East and Africa Gammaretroviral Vector Historic Market Size by Country
9.1.1 Middle East and Africa Gammaretroviral Vector Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Gammaretroviral Vector Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Gammaretroviral Vector Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Gammaretroviral Vector Forecasted Market Size by Country
9.2.1 Middle East and Africa Gammaretroviral Vector Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Gammaretroviral Vector Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novasep
10.1.1 Novasep Company Information
10.1.2 Novasep Introduction and Business Overview
10.1.3 Novasep Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novasep Gammaretroviral Vector Products Offered
10.1.5 Novasep Recent Development
10.2 MerckKGaA
10.2.1 MerckKGaA Company Information
10.2.2 MerckKGaA Introduction and Business Overview
10.2.3 MerckKGaA Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.2.4 MerckKGaA Gammaretroviral Vector Products Offered
10.2.5 MerckKGaA Recent Development
10.3 Charles River Laboratories
10.3.1 Charles River Laboratories Company Information
10.3.2 Charles River Laboratories Introduction and Business Overview
10.3.3 Charles River Laboratories Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Charles River Laboratories Gammaretroviral Vector Products Offered
10.3.5 Charles River Laboratories Recent Development
10.4 UniQure N.V.
10.4.1 UniQure N.V. Company Information
10.4.2 UniQure N.V. Introduction and Business Overview
10.4.3 UniQure N.V. Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.4.4 UniQure N.V. Gammaretroviral Vector Products Offered
10.4.5 UniQure N.V. Recent Development
10.5 Waisman Biomanufacturing
10.5.1 Waisman Biomanufacturing Company Information
10.5.2 Waisman Biomanufacturing Introduction and Business Overview
10.5.3 Waisman Biomanufacturing Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Waisman Biomanufacturing Gammaretroviral Vector Products Offered
10.5.5 Waisman Biomanufacturing Recent Development
10.6 Creative-Biogene
10.6.1 Creative-Biogene Company Information
10.6.2 Creative-Biogene Introduction and Business Overview
10.6.3 Creative-Biogene Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Creative-Biogene Gammaretroviral Vector Products Offered
10.6.5 Creative-Biogene Recent Development
10.7 Aldevron
10.7.1 Aldevron Company Information
10.7.2 Aldevron Introduction and Business Overview
10.7.3 Aldevron Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Aldevron Gammaretroviral Vector Products Offered
10.7.5 Aldevron Recent Development
10.8 Addgene
10.8.1 Addgene Company Information
10.8.2 Addgene Introduction and Business Overview
10.8.3 Addgene Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Addgene Gammaretroviral Vector Products Offered
10.8.5 Addgene Recent Development
10.9 Oxford Biomedica
10.9.1 Oxford Biomedica Company Information
10.9.2 Oxford Biomedica Introduction and Business Overview
10.9.3 Oxford Biomedica Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Oxford Biomedica Gammaretroviral Vector Products Offered
10.9.5 Oxford Biomedica Recent Development
10.10 Thermo Fisher Scientific Inc.
10.10.1 Thermo Fisher Scientific Inc. Company Information
10.10.2 Thermo Fisher Scientific Inc. Introduction and Business Overview
10.10.3 Thermo Fisher Scientific Inc. Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Thermo Fisher Scientific Inc. Gammaretroviral Vector Products Offered
10.10.5 Thermo Fisher Scientific Inc. Recent Development
10.11 Fujifilm Corporation
10.11.1 Fujifilm Corporation Company Information
10.11.2 Fujifilm Corporation Introduction and Business Overview
10.11.3 Fujifilm Corporation Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Fujifilm Corporation Gammaretroviral Vector Products Offered
10.11.5 Fujifilm Corporation Recent Development
10.12 Spark Therapeutics Inc
10.12.1 Spark Therapeutics Inc Company Information
10.12.2 Spark Therapeutics Inc Introduction and Business Overview
10.12.3 Spark Therapeutics Inc Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Spark Therapeutics Inc Gammaretroviral Vector Products Offered
10.12.5 Spark Therapeutics Inc Recent Development
10.13 ABL Inc
10.13.1 ABL Inc Company Information
10.13.2 ABL Inc Introduction and Business Overview
10.13.3 ABL Inc Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.13.4 ABL Inc Gammaretroviral Vector Products Offered
10.13.5 ABL Inc Recent Development
10.14 Boehringer Ingelheim International GmbH
10.14.1 Boehringer Ingelheim International GmbH Company Information
10.14.2 Boehringer Ingelheim International GmbH Introduction and Business Overview
10.14.3 Boehringer Ingelheim International GmbH Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Boehringer Ingelheim International GmbH Gammaretroviral Vector Products Offered
10.14.5 Boehringer Ingelheim International GmbH Recent Development
10.15 Brammer Bio
10.15.1 Brammer Bio Company Information
10.15.2 Brammer Bio Introduction and Business Overview
10.15.3 Brammer Bio Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Brammer Bio Gammaretroviral Vector Products Offered
10.15.5 Brammer Bio Recent Development
10.16 Creative Biogene
10.16.1 Creative Biogene Company Information
10.16.2 Creative Biogene Introduction and Business Overview
10.16.3 Creative Biogene Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Creative Biogene Gammaretroviral Vector Products Offered
10.16.5 Creative Biogene Recent Development
10.17 General Electric
10.17.1 General Electric Company Information
10.17.2 General Electric Introduction and Business Overview
10.17.3 General Electric Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.17.4 General Electric Gammaretroviral Vector Products Offered
10.17.5 General Electric Recent Development
10.18 Pfizer Inc
10.18.1 Pfizer Inc Company Information
10.18.2 Pfizer Inc Introduction and Business Overview
10.18.3 Pfizer Inc Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Pfizer Inc Gammaretroviral Vector Products Offered
10.18.5 Pfizer Inc Recent Development
10.19 Genezen
10.19.1 Genezen Company Information
10.19.2 Genezen Introduction and Business Overview
10.19.3 Genezen Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Genezen Gammaretroviral Vector Products Offered
10.19.5 Genezen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gammaretroviral Vector Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gammaretroviral Vector Industrial Chain Analysis
11.4 Gammaretroviral Vector Market Dynamics
11.4.1 Gammaretroviral Vector Industry Trends
11.4.2 Gammaretroviral Vector Market Drivers
11.4.3 Gammaretroviral Vector Market Challenges
11.4.4 Gammaretroviral Vector Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gammaretroviral Vector Distributors
12.3 Gammaretroviral Vector Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Lentiviral Vectors
Table 2. Major Company of Adenoviral Vectors
Table 3. Major Company of Adeno-Associated Viral Vectors
Table 4. Major Company of Other
Table 5. Global Gammaretroviral Vector Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Gammaretroviral Vector Sales by Type (2018-2024) & (K Units)
Table 7. Global Gammaretroviral Vector Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Gammaretroviral Vector Sales by Type (2018-2024) & (US& Million)
Table 9. Global Gammaretroviral Vector Market Share in Value by Type (2018-2024)
Table 10. Global Gammaretroviral Vector Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Gammaretroviral Vector Sales by Type (2024-2029) & (K Units)
Table 12. Global Gammaretroviral Vector Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Gammaretroviral Vector Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Gammaretroviral Vector Sales Market Share in Value by Type (2024-2029)
Table 15. Global Gammaretroviral Vector Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Gammaretroviral Vector Sales by Type (2018-2024) & (K Units)
Table 17. North America Gammaretroviral Vector Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Gammaretroviral Vector Sales (K Units) by Type (2018-2024)
Table 19. Europe Gammaretroviral Vector Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Gammaretroviral Vector Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Gammaretroviral Vector Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Gammaretroviral Vector Sales (K Units) by Type (2018-2024)
Table 23. Latin America Gammaretroviral Vector Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Gammaretroviral Vector Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Gammaretroviral Vector Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Gammaretroviral Vector Sales by Company (2018-2024) & (K Units)
Table 27. Global Gammaretroviral Vector Sales Share by Company (2018-2024)
Table 28. Global Gammaretroviral Vector Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Gammaretroviral Vector Revenue Share by Company (2018-2024)
Table 30. Global Market Gammaretroviral Vector Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Gammaretroviral Vector Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Gammaretroviral Vector Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gammaretroviral Vector as of 2022)
Table 34. Date of Key Manufacturers Enter into Gammaretroviral Vector Market
Table 35. Key Manufacturers Gammaretroviral Vector Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Gammaretroviral Vector Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Gammaretroviral Vector Sales by Region (2018-2024) & (K Units)
Table 39. Global Gammaretroviral Vector Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Gammaretroviral Vector Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Gammaretroviral Vector Sales Market Share in Value by Region (2018-2024)
Table 42. Global Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Gammaretroviral Vector Sales by Region (2024-2029) & (K Units)
Table 44. Global Gammaretroviral Vector Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Gammaretroviral Vector Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Gammaretroviral Vector Sales Market Share in Value by Region (2024-2029)
Table 47. Global Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Gammaretroviral Vector Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Gammaretroviral Vector Sales by Application (2018-2024) & (K Units)
Table 50. Global Gammaretroviral Vector Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Gammaretroviral Vector Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Gammaretroviral Vector Sales Market Share in Value by Application (2018-2024)
Table 53. Global Gammaretroviral Vector Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Gammaretroviral Vector Sales by Application (2024-2029) & (K Units)
Table 55. Global Gammaretroviral Vector Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Gammaretroviral Vector Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Gammaretroviral Vector Sales Market Share in Value by Application (2024-2029)
Table 58. Global Gammaretroviral Vector Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Gammaretroviral Vector Sales by Application (2018-2024) (K Units)
Table 60. North America Gammaretroviral Vector Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Gammaretroviral Vector Sales by Application (2018-2024) (K Units)
Table 62. Europe Gammaretroviral Vector Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Gammaretroviral Vector Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Gammaretroviral Vector Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Gammaretroviral Vector Sales by Application (2018-2024) (K Units)
Table 66. Latin America Gammaretroviral Vector Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Gammaretroviral Vector Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Gammaretroviral Vector Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Gammaretroviral Vector Sales by Country (2018-2024) & (K Units)
Table 70. North America Gammaretroviral Vector Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Gammaretroviral Vector Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Gammaretroviral Vector Sales Market Share in Value by Country (2018-2024)
Table 73. North America Gammaretroviral Vector Sales by Country (2024-2029) & (K Units)
Table 74. North America Gammaretroviral Vector Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Gammaretroviral Vector Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Gammaretroviral Vector Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Gammaretroviral Vector Sales by Country (2018-2024) & (K Units)
Table 78. Europe Gammaretroviral Vector Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Gammaretroviral Vector Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Gammaretroviral Vector Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Gammaretroviral Vector Sales by Country (2024-2029) & (K Units)
Table 82. Europe Gammaretroviral Vector Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Gammaretroviral Vector Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Gammaretroviral Vector Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Gammaretroviral Vector Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Gammaretroviral Vector Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Gammaretroviral Vector Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Gammaretroviral Vector Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Gammaretroviral Vector Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Gammaretroviral Vector Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Gammaretroviral Vector Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Gammaretroviral Vector Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Gammaretroviral Vector Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Gammaretroviral Vector Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Gammaretroviral Vector Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Gammaretroviral Vector Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Gammaretroviral Vector Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Gammaretroviral Vector Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Gammaretroviral Vector Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Gammaretroviral Vector Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Gammaretroviral Vector Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Gammaretroviral Vector Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Gammaretroviral Vector Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Gammaretroviral Vector Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Gammaretroviral Vector Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Gammaretroviral Vector Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Gammaretroviral Vector Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Gammaretroviral Vector Sales Market Share in Value by Country (2024-2029)
Table 109. Novasep Company Information
Table 110. Novasep Introduction and Business Overview
Table 111. Novasep Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Novasep Gammaretroviral Vector Product
Table 113. Novasep Recent Development
Table 114. MerckKGaA Company Information
Table 115. MerckKGaA Introduction and Business Overview
Table 116. MerckKGaA Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. MerckKGaA Gammaretroviral Vector Product
Table 118. MerckKGaA Recent Development
Table 119. Charles River Laboratories Company Information
Table 120. Charles River Laboratories Introduction and Business Overview
Table 121. Charles River Laboratories Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Charles River Laboratories Gammaretroviral Vector Product
Table 123. Charles River Laboratories Recent Development
Table 124. UniQure N.V. Company Information
Table 125. UniQure N.V. Introduction and Business Overview
Table 126. UniQure N.V. Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. UniQure N.V. Gammaretroviral Vector Product
Table 128. UniQure N.V. Recent Development
Table 129. Waisman Biomanufacturing Company Information
Table 130. Waisman Biomanufacturing Introduction and Business Overview
Table 131. Waisman Biomanufacturing Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Waisman Biomanufacturing Gammaretroviral Vector Product
Table 133. Waisman Biomanufacturing Recent Development
Table 134. Creative-Biogene Company Information
Table 135. Creative-Biogene Introduction and Business Overview
Table 136. Creative-Biogene Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Creative-Biogene Gammaretroviral Vector Product
Table 138. Creative-Biogene Recent Development
Table 139. Aldevron Company Information
Table 140. Aldevron Introduction and Business Overview
Table 141. Aldevron Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Aldevron Gammaretroviral Vector Product
Table 143. Aldevron Recent Development
Table 144. Addgene Company Information
Table 145. Addgene Introduction and Business Overview
Table 146. Addgene Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Addgene Gammaretroviral Vector Product
Table 148. Addgene Recent Development
Table 149. Oxford Biomedica Company Information
Table 150. Oxford Biomedica Introduction and Business Overview
Table 151. Oxford Biomedica Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Oxford Biomedica Gammaretroviral Vector Product
Table 153. Oxford Biomedica Recent Development
Table 154. Thermo Fisher Scientific Inc. Company Information
Table 155. Thermo Fisher Scientific Inc. Introduction and Business Overview
Table 156. Thermo Fisher Scientific Inc. Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Thermo Fisher Scientific Inc. Gammaretroviral Vector Product
Table 158. Thermo Fisher Scientific Inc. Recent Development
Table 159. Fujifilm Corporation Company Information
Table 160. Fujifilm Corporation Introduction and Business Overview
Table 161. Fujifilm Corporation Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Fujifilm Corporation Gammaretroviral Vector Product
Table 163. Fujifilm Corporation Recent Development
Table 164. Spark Therapeutics Inc Company Information
Table 165. Spark Therapeutics Inc Introduction and Business Overview
Table 166. Spark Therapeutics Inc Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Spark Therapeutics Inc Gammaretroviral Vector Product
Table 168. Spark Therapeutics Inc Recent Development
Table 169. ABL Inc Company Information
Table 170. ABL Inc Introduction and Business Overview
Table 171. ABL Inc Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. ABL Inc Gammaretroviral Vector Product
Table 173. ABL Inc Recent Development
Table 174. Boehringer Ingelheim International GmbH Company Information
Table 175. Boehringer Ingelheim International GmbH Introduction and Business Overview
Table 176. Boehringer Ingelheim International GmbH Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Boehringer Ingelheim International GmbH Gammaretroviral Vector Product
Table 178. Boehringer Ingelheim International GmbH Recent Development
Table 179. Brammer Bio Company Information
Table 180. Brammer Bio Introduction and Business Overview
Table 181. Brammer Bio Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Brammer Bio Gammaretroviral Vector Product
Table 183. Brammer Bio Recent Development
Table 184. Creative Biogene Company Information
Table 185. Creative Biogene Introduction and Business Overview
Table 186. Creative Biogene Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Creative Biogene Gammaretroviral Vector Product
Table 188. Creative Biogene Recent Development
Table 189. General Electric Company Information
Table 190. General Electric Introduction and Business Overview
Table 191. General Electric Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 192. General Electric Gammaretroviral Vector Product
Table 193. General Electric Recent Development
Table 194. Pfizer Inc Company Information
Table 195. Pfizer Inc Introduction and Business Overview
Table 196. Pfizer Inc Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 197. Pfizer Inc Gammaretroviral Vector Product
Table 198. Pfizer Inc Recent Development
Table 199. Genezen Company Information
Table 200. Genezen Introduction and Business Overview
Table 201. Genezen Gammaretroviral Vector Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 202. Genezen Gammaretroviral Vector Product
Table 203. Genezen Recent Development
Table 204. Key Raw Materials Lists
Table 205. Raw Materials Key Suppliers Lists
Table 206. Gammaretroviral Vector Market Trends
Table 207. Gammaretroviral Vector Market Drivers
Table 208. Gammaretroviral Vector Market Challenges
Table 209. Gammaretroviral Vector Market Restraints
Table 210. Gammaretroviral Vector Distributors List
Table 211. Gammaretroviral Vector Downstream Customers
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Gammaretroviral Vector Product Picture
Figure 2. Global Gammaretroviral Vector Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Gammaretroviral Vector Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Gammaretroviral Vector Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Lentiviral Vectors
Figure 6. Global Lentiviral Vectors Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Adenoviral Vectors
Figure 8. Global Adenoviral Vectors Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Adeno-Associated Viral Vectors
Figure 10. Global Adeno-Associated Viral Vectors Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Gammaretroviral Vector Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Gammaretroviral Vector Sales Market Share by Type in 2022 & 2029
Figure 15. North America Gammaretroviral Vector Sales Market Share in Volume by Type in 2022
Figure 16. North America Gammaretroviral Vector Sales Market Share in Value by Type in 2022
Figure 17. Europe Gammaretroviral Vector Sales Market Share in Volume by Type in 2022
Figure 18. Europe Gammaretroviral Vector Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Gammaretroviral Vector Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Gammaretroviral Vector Sales Market Share in Value by Type in 2022
Figure 21. Latin America Gammaretroviral Vector Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Gammaretroviral Vector Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Gammaretroviral Vector Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Gammaretroviral Vector Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Gammaretroviral Vector Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Gammaretroviral Vector Revenue in 2022
Figure 27. Gammaretroviral Vector Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Gene Therapy
Figure 29. Global Gene Therapy Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Vaccinology
Figure 31. Global Vaccinology Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Gammaretroviral Vector Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Gammaretroviral Vector Sales Market Share by Application in 2022 & 2029
Figure 36. North America Gammaretroviral Vector Sales Market Share in Volume by Application in 2022
Figure 37. North America Gammaretroviral Vector Sales Market Share in Value by Application in 2022
Figure 38. Europe Gammaretroviral Vector Sales Market Share in Volume by Application in 2022
Figure 39. Europe Gammaretroviral Vector Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Gammaretroviral Vector Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Gammaretroviral Vector Sales Market Share in Value by Application in 2022
Figure 42. Latin America Gammaretroviral Vector Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Gammaretroviral Vector Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Gammaretroviral Vector Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Gammaretroviral Vector Manufacturing Cost Structure
Figure 47. Gammaretroviral Vector Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries